Publication:
The inflammatory mechanisms in schizophrenia

dc.contributor.authorARICIOĞLU, FEYZA
dc.contributor.authorsErkmen, Tugba; Sahin, Ceren; Aricioglu, Feyza
dc.date.accessioned2022-03-13T12:47:02Z
dc.date.accessioned2026-01-11T13:20:20Z
dc.date.available2022-03-13T12:47:02Z
dc.date.issued2015
dc.description.abstractSchizophrenia is a serious mental illness that affects approximately 1% of the population worldwide, with chronic symptoms and significant impairment in psychosocial functioning. Interactions between genetic susceptibility and environmental stressors at the early stages of life, subsequently neurodegeneration process are important in the development of schizophrenia. Current approaches suggest that cytokines might have a role in the development of several psychiatric disorders, including schizophrenia. Uncontrolled activity of proinflammatory cytokines and microglia can induce schizophrenia in tandem with genetic vulnerability and neurotransmitter dysfunctions. Microglial activation induced by pro-inflammatory cytokines in central nervous system is responsible for the initiation and proceeding of inflammatory process and consequently developing neurodegeneration. Here in this review, we aimed to provide an overview to the latest findings related to the cytokines-mediated peripheral and central immune responses in the development of schizophrenia.
dc.identifier.doi10.5455/musbed.20150604063023
dc.identifier.issn2459-1459
dc.identifier.urihttps://hdl.handle.net/11424/238014
dc.identifier.wosWOS:000435265800008
dc.language.isotur
dc.publisherAVES PRESS LTD
dc.relation.ispartofCLINICAL AND EXPERIMENTAL HEALTH SCIENCES
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectSchizophrenia
dc.subjectcytokine
dc.subjectneuroinflammation
dc.titleThe inflammatory mechanisms in schizophrenia
dc.typearticle
dspace.entity.typePublication
oaire.citation.endPage139
oaire.citation.issue2
oaire.citation.startPage134
oaire.citation.titleCLINICAL AND EXPERIMENTAL HEALTH SCIENCES
oaire.citation.volume5

Files